These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 23886144

  • 1. Hepatitis B virus genetic variation and TP53 R249S mutation in patients with hepatocellular carcinoma in Thailand.
    Thongbai C, Sa-nguanmoo P, Kranokpiruk P, Poovorawan K, Poovorawan Y, Tangkijvanich P.
    Asian Pac J Cancer Prev; 2013; 14(6):3555-9. PubMed ID: 23886144
    [Abstract] [Full Text] [Related]

  • 2. Prevalence of aflatoxin induced p53 mutation at codon 249 (R249s) in hepatocellular carcinoma patients with and without hepatitis B surface antigen (HBsAg).
    Chittmittrapap S, Chieochansin T, Chaiteerakij R, Treeprasertsuk S, Klaikaew N, Tangkijvanich P, Komolmit P, Poovorawan Y.
    Asian Pac J Cancer Prev; 2013; 14(12):7675-9. PubMed ID: 24460352
    [Abstract] [Full Text] [Related]

  • 3. Seasonal variation in TP53 R249S-mutated serum DNA with aflatoxin exposure and hepatitis B virus infection.
    Villar S, Le Roux-Goglin E, Gouas DA, Plymoth A, Ferro G, Boniol M, Lereau M, Bah E, Hall AJ, Wild CP, Mendy M, Norder H, van der Sande M, Whittle H, Friesen MD, Groopman JD, Hainaut P.
    Environ Health Perspect; 2011 Nov; 119(11):1635-40. PubMed ID: 21768053
    [Abstract] [Full Text] [Related]

  • 4. TP53 R249S mutation, genetic variations in HBX and risk of hepatocellular carcinoma in The Gambia.
    Gouas DA, Villar S, Ortiz-Cuaran S, Legros P, Ferro G, Kirk GD, Lesi OA, Mendy M, Bah E, Friesen MD, Groopman J, Chemin I, Hainaut P.
    Carcinogenesis; 2012 Jun; 33(6):1219-24. PubMed ID: 22759751
    [Abstract] [Full Text] [Related]

  • 5. Naturally occurring basal core promoter A1762T/G1764A dual mutations increase the risk of HBV-related hepatocellular carcinoma: a meta-analysis.
    Yang Z, Zhuang L, Lu Y, Xu Q, Tang B, Chen X.
    Oncotarget; 2016 Mar 15; 7(11):12525-36. PubMed ID: 26848866
    [Abstract] [Full Text] [Related]

  • 6. TP53 R249S mutations, exposure to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort of chronic hepatitis B virus carriers from Qidong, China.
    Szymañska K, Chen JG, Cui Y, Gong YY, Turner PC, Villar S, Wild CP, Parkin DM, Hainaut P.
    Cancer Epidemiol Biomarkers Prev; 2009 May 15; 18(5):1638-43. PubMed ID: 19366907
    [Abstract] [Full Text] [Related]

  • 7. Droplet digital PCR detects high rate of TP53 R249S mutants in cell-free DNA of middle African patients with hepatocellular carcinoma.
    Marchio A, Amougou Atsama M, Béré A, Komas NP, Noah Noah D, Atangana PJA, Camengo-Police SM, Njouom R, Bekondi C, Pineau P.
    Clin Exp Med; 2018 Aug 15; 18(3):421-431. PubMed ID: 29749584
    [Abstract] [Full Text] [Related]

  • 8. Association between HBX status, aflatoxin-induced R249S TP53 mutation and risk of hepatocellular carcinoma in a case-control study from Thailand.
    Ortiz-Cuaran S, Villar S, Gouas D, Ferro G, Plymoth A, Khuhaprema T, Kalalak A, Sangrajrang S, Friesen MD, Groopman JD, Hainaut P.
    Cancer Lett; 2013 Apr 30; 331(1):46-51. PubMed ID: 23200676
    [Abstract] [Full Text] [Related]

  • 9. The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure.
    Qi LN, Bai T, Chen ZS, Wu FX, Chen YY, De Xiang B, Peng T, Han ZG, Li LQ.
    Liver Int; 2015 Mar 30; 35(3):999-1009. PubMed ID: 24461059
    [Abstract] [Full Text] [Related]

  • 10. Hepatitis B virus subgenotype C2- and B2-associated mutation patterns may be responsible for liver cirrhosis and hepatocellular carcinoma, respectively.
    Chen YM, Wu SH, Qiu CN, Yu DJ, Wang XJ.
    Braz J Med Biol Res; 2013 Jul 30; 46(7):614-22. PubMed ID: 23903686
    [Abstract] [Full Text] [Related]

  • 11. Genomic change in hepatitis B virus associated with development of hepatocellular carcinoma.
    Lee D, Lyu H, Chung YH, Kim JA, Mathews P, Jaffee E, Zheng L, Yu E, Lee YJ, Ryu SH.
    World J Gastroenterol; 2016 Jun 21; 22(23):5393-9. PubMed ID: 27340355
    [Abstract] [Full Text] [Related]

  • 12. Single Nucleotide Polymorphisms in STAT3 and STAT4 and Risk of Hepatocellular Carcinoma in Thai Patients with Chronic Hepatitis B.
    Chanthra N, Payungporn S, Chuaypen N, Piratanantatavorn K, Pinjaroen N, Poovorawan Y, Tangkijvanich P.
    Asian Pac J Cancer Prev; 2015 Jun 21; 16(18):8405-10. PubMed ID: 26745093
    [Abstract] [Full Text] [Related]

  • 13. Combinations of eight key mutations in the X/preC region and genomic activity of hepatitis B virus are associated with hepatocellular carcinoma.
    Park YM, Jang JW, Yoo SH, Kim SH, Oh IM, Park SJ, Jang YS, Lee SJ.
    J Viral Hepat; 2014 Mar 21; 21(3):171-7. PubMed ID: 24344773
    [Abstract] [Full Text] [Related]

  • 14. [Analysis of the relationship between hepatitis B virus precore and basal core promoter mutations and acute-on-chronic liver failure].
    Ma XY, Han T, Pei YZ, Zhao ZG, Gao YT, Li Y, Jing L.
    Zhonghua Gan Zang Bing Za Zhi; 2012 Sep 21; 20(9):644-8. PubMed ID: 23207226
    [Abstract] [Full Text] [Related]

  • 15. Hepatitis B virus BCP, Precore/core, X gene mutations/genotypes and the risk of hepatocellular carcinoma in India.
    Asim M, Malik A, Sarma MP, Polipalli SK, Begum N, Ahmad I, Khan LA, Husain SA, Akhtar N, Husain S, Thayumanavan L, Singla R, Kar P.
    J Med Virol; 2010 Jul 21; 82(7):1115-25. PubMed ID: 20513073
    [Abstract] [Full Text] [Related]

  • 16. The Effect of ICOS Polymorphism Interactions with HBV Mutations on HBV Subtype Infection Outcomes.
    Song XM, Li QL, Guo F, Peng H, Guo JJ.
    Ann Hepatol; 2018 Oct 16; 17(6):940-947. PubMed ID: 30600290
    [Abstract] [Full Text] [Related]

  • 17. Role of viral genotypes and hepatitis B viral mutants in the risk of hepatocellular carcinoma associated with hepatitis B and C dual infection.
    Hung CH, Chen CH, Lee CM, Hu TH, Lu SN, Wang JH, Huang CM.
    Intervirology; 2013 Oct 16; 56(5):316-24. PubMed ID: 23838434
    [Abstract] [Full Text] [Related]

  • 18. CYP2C19 Genotype Could be a Predictive Factor for Aggressive Manifestations of Hepatocellular Carcinoma Related with Chronic Hepatitis B Infection in Thailand.
    Nun-Anan P, Chonprasertsuk S, Siramolpiwat S, Tangaroonsanti A, Bhanthumkomol P, Pornthisarn B, Vilaichone RK.
    Asian Pac J Cancer Prev; 2015 Oct 16; 16(8):3253-6. PubMed ID: 25921128
    [Abstract] [Full Text] [Related]

  • 19. Hepatitis B Virus Combo Mutations Improve the Prediction and Active Prophylaxis of Hepatocellular Carcinoma: A Clinic-Based Cohort Study.
    Yin J, Wang J, Pu R, Xin H, Li Z, Han X, Ding Y, Du Y, Liu W, Deng Y, Ji X, Wu M, Yu M, Zhang H, Wang H, Thompson TC, Ni W, Cao G.
    Cancer Prev Res (Phila); 2015 Oct 16; 8(10):978-88. PubMed ID: 26290395
    [Abstract] [Full Text] [Related]

  • 20. Complete genome sequencing and clinical analysis of intrahepatic hepatitis B virus cccDNA from HCC.
    Jiao F, Long L, Ding S, Xie X, Jia L, Lu F.
    Microb Pathog; 2017 Aug 16; 109():49-55. PubMed ID: 28478205
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.